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The normal heart rhythm is guaranteed by an important 
intercellular junctions system, named Gap Junction (GJs). Each 
GJs consists of two units called connexons formed by six 
specific trans-membrane proteins named connexins (Cx). Recent 
reports suggest the presence of Cx43 in the inner mitochondrial 
membrane where it plays an important cardioprotection 
mechanism. Alterations in Cx43 expression and distribution 
were observed in several myocardium disease; i.e. in 
hypertrophic cardiomyopathy, heart failure and ischemia. Thus, 
in this doctoral study, we investigated the role  of Cx43, and in 
particular of mitochondrial Cx43, in different cardiomyopaties 
models. 
At first, we have investigated the involvement of mitochondrial 
Cx43 in an in vitro model of chemical hypoxia. Hypoxia was 
induced by adding Cobalt Chloride (CoCl2) on H9c2 
cardiomyoblast cell line, both in absence and in presence of 
Radicicol, an Hsp 90 inhibitor that blocks Cx43 translocation to 
the mitochondria. Our results showed that CoCl2 reduces the 
expression of Cx43 on the cell membrane and, moreover, it 
increases Cx43 expression at mitochondrial level, where it is 
involved in the regulation of reactive oxygen species production, 
 
 
calcium storage and mitochondrial membrane depolarization. 
Furthermore, in an in vivo Doxorubicin (DOXO)-induced 
cardiotoxicity in a short-term mouse model we have studied the 
modulation of Cx43 expression/activity and its dysregulation. 
Our results showed that DOXO is able to induce significant 
changes in calcium homeostasis and alterations in Cx43 
expression and localization. These effects are evident even in 
the heart of mice that received a single DOXO-administration. 
Finally, we have investigated if the pretreatment with Diazoxide 
(DZX), an opener of mitochondrial KATP-channels, attenuates 
DOXO-induced cardiotoxicity in a short-term mouse model. 
Our results demonstrate that DZX represents a promising 
protective intervention against DOXO-induced cardiotoxicity, 
by reducing the calcium homeostasis alteration and trying to 
restore the major cardiac parameters altered by DOXO 
treatment. This is in agreement with our hypothesis that 
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The steady beat of our hearts is among the most critical 
functions performed perfectly by our body without the 
conscious intervention. The developing heart is the earliest 
organ to function in the embryo, generating rhythmic 
contractions while it is forming, before there is blood to pump. 
Although the heart is composed of multiple cell types besides 
muscle cells, keeping a steady heartbeat is the job of specialized 
cardiomyocytes that ensure coordination of electrical signals 
throughout the organ [Rosenthal N.N et al., 2017]. 
Cardiac conduction has classically been viewed as an 
electrotonic process occurring by means of direct ionic current 
flow from cell to cell via Gap Junctions (GJs) [Kleber et al., 
2004]. GJs are intracellular structures that provide connections 
and communication between cells, allowing the passage of ions 
and small molecoles such as ATP, glutathione, cAMP, IP3 and 
glucose [Pecoraro et al., 2015 a]. To form a GJ, six  trans-
membrane monomers (connexins) from one cell oligemarize to 
form a tran-smembrane channel referred to as a connexon or 
hemichannel. The connexons from one cell then dock and 
couple with apposing connexons on neighboring cells and 
coalesce into dense GJ plaque [Basheer et al., 2016]. Connexins 
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are ubiquitous trans-membrane proteins and they are encoded by 
over 20 different genes in the mouse genome and 21 in the 
human genome, which are classified according to their different 
molecular weights that range between 26 and 60 kDa [Pecoraro 
et al., 2015 a]. Each connexin is constituted by four trans-
membrane domains, two extracellular loops (EL) and one 
intracellular; amino and carboxy terminal regions are both 
located in the cytosol [Solan and Lampe, 2005]. 
 
 
Figure 1: The image shows a GJ and its main element.[LadyofHats et al., 2006]  
Connexin 43 (Cx43) is the major connexin expressed in the 
cardiac ventricle, [Willecke et al., 2002; Pecoraro et al., 2017 a], 
which regulate intercellular coupling, conduction velocity, and 
anisotropy [Cabo et al., 2009]. It is also responsible for the 
action potential propagation [Severs et al., 2008] and  it 
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critically regulate intercellular translocation of ions and small 
molecoles [Van Veen et al., 2001]. Indeed, many reports have 
suggested that Cx43 regulates other cellular mechanisms, 
including the cell cycle, differentiation, proliferation [Kardami 
et al., 2007], maintenance of tissue homeostasis, and 
embryogenesis [De Maio et al., 2002]. 
 
Figure 2: Molecular Organization, Gating, and Function of Gap Junction Channels 
[Feliksas et al., 2013] 
 
Cx43 has a short half-life (1–3 hours in the myocardium) 
[Beardslee et al., 1998; Smyth et al., 2014]. It oligomerizes in 
the Golgi/trans-Golgi network and, after assembly, it is 
transported to the non-junctional plasma membrane through the 
cytoskeleton. Once inserted into the cell membrane, Cx43 




[Sáeza et al., 2010].  
In the heart, localization of Cx43 at the intercalated discs is 
crucial to provide the intercellular coupling necessary for rapid 
action potential propagation through the myocardium and 
synchronized cardiac contraction [Rohr et al., 2004]. 
Cx43 hemichannels can occur as free, non-junctional channels 
in the plasma membrane. These hemichannels are normally 
closed but may open in response to various triggers including 
cell depolarization, decreased extracellular Ca
2+
 ion 
concentration, increased intracellular Ca
2+
 concentration and 
alterations in the phosphorylation or redox status [Basheer et al., 
2016]. Generally, it has been assumed that the opening of 
plasma membrane Cx43 hemichannels is linked to pathological 
rather than physiological entities, contributing to cell swelling 
and cell death.  In the cardiac cells, excessive hemichannel 




 and the escape of K
+
, 
adenosine triphosphate (ATP) and other small metabolites, 
leading to osmotic shifts, energy depletion, Ca
2+
 overload and 
cell death promotion [Schulz et al., 2015]. Therefore, blockage 
of the Cx43 hemichannels by using pharmacological inhibitors 
can possibly have protective effects against cardiac insult such 
as in the case of ischemia/reperfusion injury [Schulz et al., 2015; 
Wang et al., 2013]. 
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Mice lacking Cx43 die shortly after birth due to cardiac 
hyperplasia obstructing the right ventricular outflow tract 
[Reaume et al., 1995], while a heart-specific conditional 
knockout exhibited arrhythmia and premature death[Gutstein et 
al., 2001a; Gutstein et al., 2001 b]. 
Cx43 is a phosphoprotein that is predominantly phosphorylated 
in the control state. There are at least 14 serines and 2 tyrosines 
in the cytoplasmic C-terminal region of Cx43 that are 
phosphorylated by a variety of kinases [Marquez-Rosado et al., 
2011], such as mitogen activated protein kinase (MAPk), protein 
kinase C (PKC), protein kinase A (PKA), casein kinase 1 and 
Src. The phosphorylation of the serine residues, like S306, S365 
and S368, modulates the conductivity of the GJs [Lampe et al., 
2000], as well as their trafficking, assembly/disassembly, 
degradation and gating [Pecoraro et al., 2015 a]. Indeed, 
connexin phosphorylation and dephosphorylation play an 
important role in regulating GJ channel function at several 






Figure 3: Connexin phosphorylation at the serine residues modulates the conductivity 
of the GJs, as well as, their trafficking, assembly/disassembly, degradation and gating 
[Solan and Lampe 2005] 
 
Most of the function ascribed to Cx43 in cardiac 
pathophysiology is within the context of its role in forming the 
GJ [Severs et al., 2004]. However, recent literature reports that 
Cx43, independent of its ability to form functional GJs, 
regulates susceptibility of cells to several cell injury paradigms 
suggesting a novel function of this protein in modulating cell 
death, specially myocyte death [Li net al., 2003].  
Cardiac mitochondria play a pivotal role in the maintenance of 
cellular bioenergetics and intracellular ion homeostasis, 
especially of calcium (Ca
2+
) and potassium (K
+
) ions. Cellular 
Ca
2+
 homeostasis is maintained in a very stringent manner by 
the cyclical uptake and release by the endoplasmic reticulum 
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and mitochondria, respectively [Gunter et al., 2004]. These 
cyclical events are crucial to ensure the cardiac rhythm and any 
disturbance may lead to arrhythmia, cell death, and tissue 
damage as observed in cardiac failure and ischemia–reperfusion 
injury [Kristia´n et al., 1998]. Many studies reported that both in 
tissue [Boengler et al., 2005; Pecoraro et al., 2017 b] and in 
isolated mitochondria [Srisakuldee et al., 2009; Pecoraro et al., 
2017 b], Cx43 is located at the inner mitochondrial membrane 
[Rodriguez-Sinovas et al., 2006] where it forms hemichannels, 
with the C-terminus region oriented at the intermembrane space 
[Miro-Casas et al., 2007].  
The physiological role of mCx43 has not been well elucidated, 
but recent studies show that it modulates K
+
 influx to the 
mitochondrial matrix, mitochondrial respiration and reactive 
oxygen species (ROS) generation [Boengler et al., 2012; Miro-
Casas et al., 2007]. Indeed, mCx43 may play a role in mediating 
the cardioprotective effect of ischemic preconditioning. 
Protection by mCx43 has been linked to ROS generation, 
mitochondrial KATP channels, protein kinase C (PKC) signaling, 
and stimulation of translocase of outer membrane- 20 (Tom20) 
that facilitates Cx43 transport [Gadicherla et al., 2017], from 
cytosol to mitochondria with a mechanism that involves heat 
shock protein 90 (Hsp90). Cytosolic Hsp90 is generally 
involved in the folding of newly synthesized proteins and its 
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role in mitochondrial import may be an extension of this activity 
[Young et al., 2003].  
In fact, mitochondrial import machinery involves binding of the 
target protein to a chaperone (Hsp90/Hsp70), presentation to 
specific parts of TOM complex, and release into the inner 
mitochondrial membrane through the TIM (Translocase of the 
Inner Membrane) [Pecoraro et al., 2015 a]. Recently it has been 
hypothesized that mCx43 protects the cells by reducing 
cytosolic Ca
2+
 overload, mitochondrial permeability transition, 
and cell death [Pecoraro et al., 2017 a; Pecoraro et al., 2017 b]. 
Cx43-based hemichannels are non-selective large conductors of 
Ca
2+
 entry in the inner mitochondrial membrane. Thus, mCx43 
may directly contribute to mitochondrial Ca
2+
 entry/overload, 







Figure 4: During biosynthesis, Cx43 is inserted into the endoplasmatic reticulum 
where it correctly folds and oligomerize in the Golgi/trans-Golgi network. After 
assembly, Cx43 hemichannel is carried on the cell surface through the cytoskeleton. 
Once inserted into the cell membrane, Cx43 spreads in the region where there are GJ 
claque by a microtubule/dynein/β-catenin/N-cadherin-dependent pathway. In addition, 
after assembly in Golgi, Cx43 may translocate from cytosol to mitochondria with a 
mechanism that involves Hsp90 and translocase of the outer membrane. This system 
involves binding of the target protein to Hsp90, presentation to specific parts of TOM 
complex, and release into the inner mitochondrial membrane [Pecoraro et al., 2015 a]. 
 
Myocyte apoptosis is now recognized to mediate cell death in a 
variety of acute and chronic heart diseases [Goubaeva et al., 
2007], and many studies confirmed the mCx43 as a novel 
regulator of mitochondrial function where inhibition results in 
the release of cytochrome C and myocyte apoptosis.  
Futhermore, mCx43 is involved in a signal transduction pathway 
that can prevent mitochondrial permeability transition pore 
(mPTP) formation [Ruiz-Meana et al., 2008]. The mPTP is a 
large non-specific conductance channel that forms at the inner 
mitochondrial membrane under conditions of calcium 
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overload/oxidative stress [Baines et al., 2007]. Once formed the 
mPTP results in mitochondrial swelling, rupture of the outer 
mitochondrial membrane, release of apoptogenic mitochondrial 
contents to the cytosol, and cell death. Signals preventing mPTP 
formation during repefusion after ischaemia promote cell 
survival and reduce myocardial damage [Martel et al., 2012]. 
Thus, Cx43 channels, both as a GJ and as a hemichannel, form 
large-conductance ion channel with chemical gating similar to 
the Bcl-2 channels. In addition, they are voltage gated perhaps 
allowing sensing of the mitochondrial membrane potential in 
addition to the chemical environment.  
Changes in Cx43 expression and/or subcellular distribution in 
the heart have been associated with a wide variety of pathologic 
conditions and diseases, including the ventricular myocardium 
and cardiac arrhythmia [Due t al., 2017; Prevedel  et al., 2017]. 
Moreover, myocardial hypoxia or ischaemia and conditions such 
as hypertrophy are associated with reduced cardiac action 
potential conduction, raised intracellular [Ca
2+
] and GJ 
uncoupling [Jabr et al., 2016]. 
These alterations contribute to abnormal impulse propagation 
and arrhythmogenic substrates leading to sudden cardiac death 
[Gutstein et al., 2001]. Arrhythmias are common complications 
of myocardial ischemia and infarction in humans. Reduced 
electrical coupling can increase the propensity for arrhythmias 
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rendering the ventricle more susceptible to re-entry. This 
condition seems to be due to dysfunction and disorganization of 
Cx43. Indeed, reduction of about 90% in Cx43 expression 
results in about 50% decrease in the conduction velocity. While 
50% reduction in Cx43 may lead to some conduction slowing, 
high levels of electrical uncoupling are needed to increase 
arrhythmogeneity [Pecoraro et al., 2015 a]. 
Therefore, a large number of studies in recent years 
demonstrated a decrease in expression and/or lateralization and 
heterogeneous distribution of Cx43 in the myocardium of 
patients with hypertrophic cardiomyopathies (HCM), dilated 
cardiomyopathies (DCM), ischemic cardiomyopathies, as well 
as clinical congestive heart failure [Basheer et al., 2016].  
 
Figure 5: Hypertrophic Cardiomyopathy and Heart Failure. Hypertrophy are 
associated with reduced cardiac action   potential conduction, raised intracellular 







In general, in these cardiomyopathies, Cx43 expression appears 
to be unaltered or up-regulated during the initial and 
compensatory phase of hypertrophy, but redistributed along the 
cardiomyocyte surface and reduced when the hypertrophy 
becomes prolonged and putatively maladaptive in its 
progression to heart failure [Birgit et al., 2004]. 
The most common myocardial dysfunction is ischemic injury, 
which is the principal cause of death in the world [Pecoraro et 











Cardiac ischemia is manifested by accumulation of metabolites 
in the extracellular compartment in combination with reduced 
oxygen supply. Furthermore ischemia induces closure of GJs, 
due to increased cytosolic Ca
2+
 concentration, reduced ATP 
concentration, changes in phosphorylation of Cx43 and 





 and accumulation of amphipathic lipid 
metabolites during ischemia promote electrical uncoupling, 
mediated by alterations in phosphorylation of Cx43. In fact, 
acute ischemia may activate or inhibit protein kinases and 
phosphatases [Beardslee et al., 2000]. Cx43 plays a crucial role 
in ischemic preconditioning cardioprotection by improving 
myocardial function [Wang et al., 2015]. 
 
Figure 7: Schematic diagram that shows the effects of Cx43 dysfunction and 




AIM OF WORK 
 
Based on the data recently reported in the literature [Pecoraro et 
al., 2015 b; Severs et al., 2004; Du et al., 2017], we 
hypothesized that GJs, particularly Cx43, are largely involved in 
mechanisms that affect different cardiac pathologies. The aim of 
this doctoral project is therefore to investigate the involvement 
of Cx43, and in particular of the mCx43, in in vitro and in vivo 
cardiomyopaties models. In addition, we will focus on specific 
drugs and on their effects on the modulation of Cx43 
expression/activity. 
-As the first we investigated the involvement of mCx43 in the 
apoptotic pathway in an in vitro model of chemical hypoxia. 
Hypoxia was induced by adding Cobalt Chloride (CoCl2) on 
H9c2 cardiomyoblast cell line, both in absence and in presence 
of Radicicol, an Hsp 90 inhibitor that blocks Cx43 translocation 
to the mitochondria.  
-As the second we investigated the involvement of Cx43 in a 
mouse model of cardiotoxicity. To this end we used a short-term 
mouse model of cardiotoxicity induced by Doxorubicin. 
 -As the third we investigated if the pretreatment with Diazoxide 
(DZX), an opener of mitochondrial KATP-channels, attenuates 
DOXO-induced cardiotoxicity and affect Cx43 expression 




Role of mitochondrial Connexin 43 in a chimical 
model of hypoxia 
 
1.1 Introduction 
Ischemic injury is the most common myocardial dysfunction, 
which is the principal cause of death in the world [Ruiz-Meana 
et al., 2001]. It’s irreversible and widespread loss of myocardial 
cells and subsequent ventricular remodeling induced by acute 
myocardial infarction are the main elements resulting in chronic 
heart failure and permanent loss of labor force [Roger et al., 
2012]. 
This cardiomyopathy is manifested by accumulation of 
metabolites in the extracellular compartment in combination 
with reduced oxygen supply [Pecoraro et al., 2015 a]. 
Ischemia triggers a decrease in GJ communication as a result of 





altered phosphorylation and nitrosylation levels [Schulz et al., 
2015]. Revascularization could improve the prognosis of the 
patients with acute myocardial infarction [Roger et al., 2012], 
however, reperfusion could induce additional injury, which is 
sometimes extremely severe or fatal. Basic studies [Jiang et al., 
2013; Wei et al., 2013] and small-sample clinical data [Crimi et 
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al., 2013] have verified that ischemic postconditioning (IPOC) 
could attenuate injury induced by ischemia/reperfusion (I/R). 
Other studies [Shimizu et al., 2014; Mykytenko et al., 2008] 
report that the Cx43 plays an important role in IPOC 
cardioprotection against I/R injury. In fact, many studies 
attribute the effect of cardioprotection to mitochondria, where 
Cx43 translocates throught Hsp90/TOM 20 machinery system 
[Goubeva et al., 2007].  
So, the first step of this phD project was to study the role of 


















1.2 Materials and Methods 
 
1.2.1 Experimental Protocols 
The hypoxia model was established by using the hypoxia-
inducing agent CoCl2 [Shi Yun et al., 2017]. CoCl2 is a well 
known chemical hypoxia mimetic agent, which can mimic 
hypoxia/hischemic conditions by causing inactivation of 
hydroxylase enzymes and stabilization of hypoxia-inducible 
factor HIF-1α [Liu et al., 2014]. H9c2 cardiomyoblasts were 
treated with CoCl2 at 50-100-150 µM for 3 or 6 h in DMEM 10 
% FBS. In order to verify the role of mCx43 in CoCl2-treated 
cells, we used Radicicol, a specific inhibitor of Hsp90 [Schulte 
et al., 1998], since the translocation of mCx43 on the 
mitochondrial membrane provides the binding of this protein to 
Hsp90 [Ruiz-Meana et al., 2008]. In the experiments that 
included the use of  Radicicol (1 µM), an Hsp90 inhibitor, it has 
been administered 30 min before CoCl2 treatment and left in the 
incubation medium for all experimental time. 
 
1.2.2 Cell Culture 
The cell line used is rat cardiomyocytes H9c2 that demonstrate 
many similarities to primary cardiomyocytes, including 
membrane morphology, G-protein signaling expression, 
electrophysiological properties and constitutive expression of 
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Cx43 [Wu et al., 2013]. H9c2 was purchased from the American 
Tissue Culture Collection (Manassas, VA, USA). 
H9c2 cells were subcultured weekly in 100-mm Corning dishes 
containing 10 ml Dulbecco’s modified Eagle’s Medium 
(DMEM; Gibco) with 10 % fetal bovine serum (FBS; Gibco) 
and antibiotics (25 U/ml penicillin and 25 U/ml streptomycin).  
 
1.2.3 MTT assays 
Cell viability was evaluated by means of MTT ([3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]). H9c2 
(3,5x10
3
 cells/well) were plated in 96-well tissue culture plates 
and allowed to adhere for 24 h. Thereafter, the medium was 
replaced with fresh medium alone or containing CoCl2 (50-100-
150µM) and incubation was performed for 3 or 6 h at 37°C in an 
atmosphere containing 5% CO2. Where indicated, Radicicol (1 
µM) was added 30 min before CoCl2. Cell mortality was 
assessed by means of MTT assay. Briefly, 25 µl of MTT (5 
mg/ml) were added and cells were incubated for an additional 
3h to allow the formation of formazan precipitate, which was 
solubilised with 100 µl of a solution containing 50% (v/v) N,N-
dimethylformamide, 20% (w/v) SDS with an adjusted pH of 4.5. 
The optical density (OD) of each well was measured with a 
microplate spectrophotometer (Titertek Multiskan MCC/340-
DASIT; Milan, Italy) equipped with a 620nm filter. H9c2 
23 
 
mortality in response to treatment with CoCl2 both in absence 
and in presence of Radicicol was calculated as % mortality = 
100-[100x(OD treated/OD control)]. 
 
1.2.4 Mitochondrial protein extraction and Western blot 
analysis for mitochondrial Cx43   
H9c2 (1x10
6
 cells/well) were seeded into Petri plates and 
allowed to adhere for 24 h. Thereafter, the medium was replaced 
with fresh medium and cells were treated as described. 
Mitochondrial protein extraction was carried out from cells in 
lysis buffer A (sucrose 250 mM, K
+
 Hepes pH 7.5 20 mM, KCl 
10 mM, MgCl2 1,5 mM, EDTA 1 mM, EGTA 1 mM, protease 
inhibitors,  NaF 50 mM, Na3VO4 0,2 mM, PMSF 1 mM, DTT 1 
mM, digitonin 0,025%). Then the cells were centrifugated at 
16000 g for 2 min at 4°C. The supernatant was discarded and the 
pellet was resuspended in lysis buffer B (NaCl 150mM, Triton 
X 1%, NaDeOH 0,5%, SDS 1% and Tris HCl 50mM pH 7.4) to 
obtain mitochondrial protein. Protein concentrations were 
determined with the Bio-Rad protein assay (BIO-RAD, Milan 
Italy). Equal amounts of protein (50 µg) were loaded into an 
acrylamide gel and separated by SDS-PAGE under denaturating 
conditions. Blots were incubated with primary antibody anti-
Cx43 (BD transduction laboratories, 1:8000) or anti-TOM20 
(1:250, used as loading control) over night. After incubation 
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with the primary antibodies and washing in PBS/0.1% Tween, 
the appropriate secondary antibody, anti-rabbit or anti-mouse 
(each diluted 1:4000) was added for 1h at room temperature. 
Immunoreactive protein bands were detected by 
chemiluminescence using enhanced chemiluminescence 
reagents (ECL) in LAS 4000 (GE Healthcare). The images were 
analysed for densiometry using ImageJ Software.  
 In order to verify the purity of mitochondrial protein extraction, 
a Western blot analysis was performed to evaluate the presence 
of proteins expressed only in the mitochondria (ox-Phos 
Complex II, Abcam, 1:7000) and the absence of proteins 





Abcam, 1:3000). The purification assay was evaluated as the 
enrichment in mitochondrial protein (anti-Ox-Phos Complex II) 





 ATPase)  by means of Western blot analysis as 
previously reported [Boengler et al., 2005]. 
 
1.2.5 Total protein extraction and Western blot analysis for 
procaspase 3 and caspase 9 
H9c2 (7x10
5
 cells/well) were seeded in 6-well tissue culture 
plates  and allowed to adhere for 24 h. Thereafter, the medium 
was replaced with fresh medium and cells were treated as 
described. Total proteins were extracted from cells by freeze/ 
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thawing in lysis buffer (containing Tris–HCl 50 mM pH 7.4, 50 
mM NaF, 150 mM NaCl, 1 % Nonidet P40, 1 mM 
phenylmethylsulfonylfluoride, 0.2 mM sodium orthovanadate, 
1mM EDTA and protease inhibitors). Protein concentrations 
were determined with the Bio-Rad protein assay (BIO-RAD, 
Milan Italy), and 50 µg protein/lane was loaded onto an 
acrylamide gel and separated by SDS-PAGE in denaturating 
conditions. Blots were incubated, over night, with primary 
antibody anti-procaspase 3 and anti-caspase 9 (each diluted 
1:200; from Santa Cruz Biotechnology, DBA Italy). GAPDH 
(1:1000) was used as loading control. After incubation with the 
primary antibodies and washing in TBS/0.1 % Tween, the 
appropriate secondary antibody, either anti-rabbit (diluted 
1:5.000), was added for 1h at room temperature. 
Immunoreactive protein bands were detected by 
chemiluminescence using enhanced chemiluminescence 
reagents (ECL) in LAS 4000 (GE Healthcare). Western blot data 
were quantified by using ImageJ Software. 
 
1.2.6 Immunofluorescence Analysis with Confocal Microscopy 
For immunofluorescence assay, H9c2 cells were seeded on 
coverslips in 12-well plate (10
4
 cells/well)  and allow to grow 
for 24 h; thereafter, the medium was replaced with fresh 
medium and cells were treated with CoCl2 (50-100-150 µM) for 
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3 or 6 h, with or without Radicicol (1µM). Then, cells were 
fixed with 4 % paraformaldehyde in PBS for 15 min and 
permeabilized with 0.1 % triton X in PBS for 15 min. After 
blocking with BSA and PBS for 1 h, cells were incubated with 
rabbit anti- HIF-1α antibody (TEMA Ricerca-Origene), mouse 
anti-Cx43 antibody (Santa Cruz Biotechnologies, 1:250) and 
rabbit anti-TOM20 (1:250) for 2 h at room temperature. The 
slides were then washed with PBS for three times and 
fluorescein-conjugated secondary antibody (FITC) or Texas red-
conjugated secondary antibody were added for 1 h, DAPI was 
used for counterstaining of nuclei. Coverslips were finally 
mounted in mounting medium and fluorescent images were 
taken under the laser confocal microscope (Leica TCS SP5). 
 
1.2.7 Measurement of Intracellular calcium Signaling 
Intracellular calcium concentrations were measured using the 
fluorescent indicator dye Fura 2-AM, the membrane- permeant 
acetoxymethyl ester form of Fura 2. Briefly, H9c2 (3x10
4
 
cells/well) were seeded in 6-well tissue culture plates and 
allowed to adhere for 24 h. Thereafter, the medium was replaced 
with fresh medium and cells were treated as described. After 
incubation period (3 or 6 h), cells were washed in phosphate 
buffered saline (PBS), re-suspended in 1 ml of Hank’s balanced 
salt solution (HBSS) containing 5 µM Fura 2-AM for 45 min. 
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Thereafter, cells were washed with the same buffer to remove 
excess Fura 2-AM and incubated in calcium-free HBSS/0.5 mM 
EGTA buffer for 15 min to allow hydrolysis of Fura 2-AM into 
its active-dye form, Fura 2. H9c2 cells then were transferred to 
the spectrofluorimeter (Perkin-Elmer LS-55). Treatment with 
Ionomycin (1 µM final concentration), or with carbonyl cyanide 
p-trifluoromethoxy-pyhenylhydrazone (FCCP, 50 nM final 
concentration) was carried out by adding the appropriate 
concentrations of each substance into the cuvette in calcium-free 
HBSS/0.5 mM EGTA buffer. The excitation wavelength was 
alternated between 340 and 380 nm, and emission fluorescence 
was recorded at 515 nm. The ratio of fluorescence intensity of 
340/380 nm (F340/F380) is strictly related to intracellular free 
calcium [Popolo et al., 2011]. Results are indicated as delta 
increase in fluorescence ratio (F340/F380 nm) induced by 
ionomycin-basal fluorescence ratio (F340/F380 nm) or FCCP-
basal fluorescence ratio (F340/F380 nm). 
 
1.2.8 Measurement of  Mitochondrial Superoxide Evaluation 
with MitoSOX Red 
Mitochondrial superoxide formation was evaluated by MitoSOX 
Red. Briefly, H9c2 (4,0x10
5
 cells/well) were plated in 6-well 
tissue culture plates  and allowed to adhere for 24 h. Thereafter, 
the medium was replaced with fresh medium and cells were 
treated as described. After incubation period, MitoSOX Red (2.5 
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µM) was added for 15 min at 37°C before fluorescence 
evaluation by means of flow cytofluorometry. This indicator is a 
fluorogenic dye for highly selective detection of superoxide in 
the mitochondria of live cells and, once targeted to the 
mitochondria, it is oxidized by superoxide and exhibits red 
fluorescence. MitoSOX is readily oxidized by superoxide but 
not by other ROS-generating systems. Cells fluorescence was 
evaluated using a fluorescence-activated cell sorting and 
analyzed with Cell Quest software. 
 
1.2.9 Measurement Mitochondrial Membrane Depolarization 
with TMRE 
Mitochondrial permeability transition pore (mPTP) opening was 
measured with FACS scan by means of the fluorescent dye, 
tetramethylrhodamine methyl ester (TMRE). Due to its positive 
charge, TMRE readily accumulates in active mitochondria in 
inverse proportion to Δψm according to the Nernst equation. For 
these experiments H9c2 (4,0x10
5
 cells/well) were seeded in 6-
well tissue culture plates  and allowed to adhere for 24 h. 
Thereafter, the medium was replaced with fresh medium and 
cells were treated as described. Cells were then collected, 
washed twice with phosphate buffer saline (PBS) and then 
incubated in PBS containing TMRE (5 nM) at 37°C. After 30 
min, cells fluorescence was evaluated using a fluorescence-
activated cell sorting and analyzed with Cell Quest software. 
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1.2.10 Cytochrome c release detection by cytofluorometry 
Cytochrome c was checked by fluorescence-activated cell 
sorting (FACSscan; Becton–Dickinson). H9c2 cells were 
cultured in a 6-well plate (4,5x10
5
 cells/well) and allow to grow 
for 24 h; thereafter, the medium was replaced with fresh 
medium and cells were treated as described. After incubation 
period, cells were harvested with scraper and treated with 
permeabilization buffer (containing 2 % FBS and PBS in the 
presence of sodium azide 0.1 %, 4 % formaldehyde and Triton 
X 0.1 %) after the treatment with fixing buffer (containing 2 % 
FBS and PBS in the presence of sodium azide 0.1 %, 4 % 
formaldehyde) for 20 min. The permeabilization of cells was 
performed for 30 min and then anti-cytochrome c antibody was 
added. Anti-rabbit FITC antibody was used as a secondary 
antibody (eBioscience, CA, USA). Cells were then washed 
twice with fixing buffer and then analyzed by means of FACS. 
Data obtained were analyzed by means of Cell Quest software. 
Results were shown as percentage of positive cells. 
 
1.2.11 Analysis of apoptosis  
Hypodiploid nuclei were analysed using propidium iodide (PI) 
staining by means of FACs. Briefly, cells were cultured in a 6-
well plate (4,5x10
5
 cells/well) and allow to grow for 24 h; 
thereafter, the medium was replaced with fresh medium and 
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cells were treated as described. After incubation period, cells 
were washed in phosphate buffered saline (PBS) and 
resuspended in 500 μL of a solution containing 0.1% sodium 
citrate, 0.1% Triton X-100 and 50 μg/mL PI. After incubation at 
4°C for 30 min in the dark, cell nuclei were analysed by means 
of FACS using CellQuest software. Cellular debris were 
excluded from the analysis by raising the forward scatter 
threshold, and the DNA content of the nuclei was registered on a 
logarithmic scale. Data are expressed as the percentage of cells 
in the hypodiploid region. 
 
1.2.12 Statistical Analysis 
Statistical analysis was performed with the aid of commercially 
available software GraphPad Prism4 (GraphPad Software Inc., 
San Diego CA, USA). Results are expressed as mean ± S.E.M. 
of at least three independent experiments, each performed in 
duplicate. Statistical analysis was performed by Student’s t test. 











1.3.1 CoCl2-induced chemical hypoxia 
CoCl2 mimics the hypoxic/ischaemic condition and is a simple 
and validated in vitro tool to study the molecular mechanisms 
driven by hypoxia [Goldberg et al., 1988]. Cells respond to 
hypoxia by activation of the hypoxia-inducible factor HIF-1α, a 
transcription factor that modulates the expression of genes 
involved in angiogenesis, survival, metabolism and cell 
migration [Pennacchietti et al., 2003].  Immunofluorescence 
analisys confirm the induction of hypoxia in cells treated with 
CoCl2 at 50-100-150µM for 3 or 6h. In fact, a marked increas of 
HIF-1α levels were observed, both in absence and in presence of 
Radicicol (1 µM) (Figure 8A). Furthermore, by means of MTT 
we observed that in our experimental model cells mortality was 













Figure 8: CoCl2 induces hypoxic state. CoCl2 (50-100-150µM) was administered 
for 3 and 6 h and H9c2 cells were stained with HIF-1α (red) and nucleus with DAPI 
(blue) and were determined by Immunofluorescence analysis. Where indicated, 
Radicicol (1µM) was administered 30 minutes before CoCl2. Scale bar, 10 µm. A 
representative of three experiments was shown. The panel B shows the cytotoxicity 
measuring the cell mortality after treatment with MTT assay. Cell viability = 
absorbance of treated sample/absorbance of control. Cells mortality was calculated as: 
% mortality = 100-[100x(OD treated/OD control)]. Results were analyzed by 
Student’s t test. *p<0.05 and ***p<0.001 vs non-treated;°p<0.05 and °°°p<0.001 vs 




1.3.2 CoCl2 increased mitochondrial Cx43 expression 
Western blot analysis showed a significant (p<0.05) increase of 
mCx43 expression in CoCl2-treated H9c2 cells already evident 
at 3h. Pre-treatment with Radicicol, significantly (p<0.05) 
reduced CoCl2-induced mCx43 over-expression at either 
experimental times (Figure 9A).  
 
Figure 9: CoCl2 increases mitochondrial Cx43 expression. CoCl2 (50-100-150µM)  
was administered for 3 and 6 h in H9c2 cells and mCx43 expressions were detected 
by Western blot analysis. TOM20 protein expression was used as loading control (A). 
Results are expressed as mean ± S.E.M. from at least three independent experiments 
each performed in duplicate. Data were analyzed by Student's t test. *p<0.05, 
**p<0.005 vs non-treated; °p<0.05 vs cells treated with Radicicol alone. 
Representative Western blots of Na+/K+ATPase and Ox-Phos Complex II were used  
as markers, respectively, to  demonstrate the purity of the mitochondrial extracts (B). 
 
Data were confirmed by immunofluorescence analysis which 
revealed that CoCl2 administration induced an increase in 






Figure 10: CoCl2 increases mitochondrial Cx43 localization. CoCl2 (50-100-
150µM) was administered for 3 and 6 h and H9c2 cells and mitochondrial localization 
of Cx43 was detected using immunofluorescence assay at confocal microscopy. 
Where indicated, Radicicol (1 µM) was administered 30 minutes before CoCl2. The 
images were obtained throught software-generated reconstructions continuously 
acquiring overlapping (Z stack) images to get the whole cell image. Scale bar, 10 µm. 




1.3.3 The inhibition of Cx43 translocation on mitochondria 
increased Mitochondrial Superoxide Production 
The mitochondrial superoxide production was checked by 
MitoSOX red. Flow cytometry analysis showed that the CoCl2 
(50-100-150μM) treatment significantly (p<0.05) increased 
mitochondrial superoxide production at both experimental times. 
Radicicol (1µM) pre-treatment, increases CoCl2-induced 
superoxide production. This effect was significant (p<0.05) only 
at 6h, even if the amount of mitochondrial superoxide 
production in H9c2 pre-treated with Radicicol at 3h was 
comparable to those of cells treated for 6h with CoCl2 alone 
(Figure 11). 
 
Figure 11: Radicicol increases mitochondrial ROS production in CoCl2 treated 
H9c2 cells. Superoxide production by mitochondria was evaluated by means of the 
probe MitoSOX Red in H9c2 cells by flow cytometry analysis. CoCl2 (50-100-
150µM) was administered for 3 and 6 h. Where indicated, Radicicol (1 µM) was 
administered 30 minutes before CoCl2. Mitochondrial superoxide production was 
expressed as mean ± S.E.M. of percentage of MitoSOX positive cells of at least three 
independent experiments each performed in duplicate. Data were analyzed by 







1.3.4 CoCl2 induces calcium homeostasis alteration 
Intracellular calcium concentrations was evaluated by means of 
FURA 2-AM in Ca
2+
-free incubation medium (containing 0.5 
mM EGTA). CoCl2-treated cells showed alteration in 
intracellular Ca
2+
 levels. In fact, delta increase in intracellular 
Ca
2+
 induced by Ionomycin in CoCl2-treated cells was 
significantly (p<0.05) higher than control cells at all 
experimental time points, indicating higher levels of Ca
2+
 in 
cellular stores. Pharmacological inhibition of Cx43 translocation 
on mitochondria by Radicicol significantly affected intracellular 
Ca
2+
 homeostasis. In fact, in Radicicol pre-treated cells, delta 
increase in intracellular Ca
2+
 was significantly higher (p<0.05) 
than cells treated with CoCl2 alone (Figure 12A). In order to 
analyze the involvement of mitochondrial Ca
2+
 content, cells 
were incubated with CoCl2 alone or pre-treated with Radicicol 
and then the mitochondrial calcium depletory, carbonyl cyanide 
p-trifluoromethoxypyhenylhydrazone FCCP (50 nM), was 
added. As reported in Figure 12B, in CoCl2-treated H9c2 cells 
delta increase in intracellular Ca
2+
 induced by FCCP was higher 
than control cells. In Radicicol pre-treated cells, delta increase in 
intracellular Ca
2+
 was significantly (p<0.05) higher than cells 
treated with CoCl2 alone, indicating higher levels of Ca
2+
 in 








Figure 12: Radicicol increases mitochondrial calcium concentrations in CoCl2 
treated H9c2 cells. CoCl2 (50-100-150µM)  was administered for 3 and 6 h. Where 
indicated, Radicicol (1 µM) was administered 30 minutes before CoCl2 . Intracellular 
calcium content was evaluated on H9c2 cells in calcium -free medium by means of 
Ionomycin (1μM) (panel A). Effect of CoCl2 on mitochondrial calcium pool was 
evaluated on H9c2 cells in calcium -free medium in presence of FCCP (50 nM) (panel 
B). Results are expressed as mean ± S.E.M. of delta (δ) increase of FURA 2 ratio 
fluorescence (340/380nm) from at least three independent experiments each 
performed in duplicate. Data were analyzed by Student’s t test. *p<0.05 and 









1.3.5 The inhibition of Cx43 Translocation Enhanced 
Mitochondrial Membrane Depolarization 
CoCl2 (50-100-150μM) administration induced the opening of 
the mitochondrial transition pore, as demonstrated by means of 
TMRE. In fact, after 3 h of CoCl2 treatment, we observed an 
increase of mitochondrial membrane depolarization. But it is 
interesting to note that inhibition of mCx43 translocation 
accelerates mitochondrial membrane depolarization. In fact, as 
reported in Figure 13, in Radicicol pre-treated cells at 3 h 
mitochondrial membrane depolarization values were higher than 
those of cells treated for 3h with CoCl2 alone and comparable to 
those observed in H9c2 treated with CoCl2 alone for 6h. 
 
 
Figure 13: Radicicol increases CoCl2-induced mitochondrial membrane potential 
collapse in H9c2 cells. CoCl2 (50-100-150µM) was administered for 3 and 6 h. 
Where indicated, Radicicol (1 µM) was administered 30 minutes before CoCl2. The 
mitochondrial membrane potential was evaluated by flow cytometry analysis with 
tetramethylrhodamina ethyl ester (TMRE), a cationic dye that gives a strong 
fluorescence signal. Results are expressed as mean ± S.E.M. of fluorescence intensity 
of at least three independent experiments each performed in duplicate. Data were 






1.3.6 Inhibition of Cx43 translocation to mitochondria enhances 
CoCl2 -induced apoptotic response 
Jung and co-workers [2004] report that one of the causes of cell 
death could be mitochondrial membrane permeabilization, 
therefore we analysed the apoptotic response in our 
experimental conditions. Treatment with CoCl2 leads to an 
increase of the cytocrome c release (Figure 14A) and in the 
number of aplodyploid nuclei (Figure 14B), as compared with 
untreated cells. In agreement with the activation of the 
mitochondrial apoptosis canonical way, Western blot analysis 
showed a significant and dose-dependent reduction of 
procaspase 3 levels and an increase caspase 9 levels in CoCl2–
treated cells (Figure 14C). Radicicol pretreatment significantly 
(p<0.05) reduced cytocrome c release and the number of 
















Figure 14: Radicicol  increased the trigger of the apoptotic pathway induced 
by CoCl2 in H9c2 cells. CoCl2 (50-100-150µM) was administered for 3 and 6 h, 
where indicated, Radicicol (1 µM) was administered 30 minutes before CoCl2. 
Cytochrome c level into the cytosol was checked by flow cytometry analysis. 
Results are expressed as mean ± S.E.M. of percentage of cytochrome c positive 
cells from at least three independent experiments each performed in duplicate 
(panel A). H9c2 were stained by propidium iodide and fluorescence of individual 
nuclei was measured by flow cytometry. Results are expressed as mean ± S.E.M. of 
percentage of hyplodiploid nuclei from at least three independent experiments each 
performed in duplicate (panel B). Caspase 9 and procaspase 3 expressions were 
detected by Western blot analysis; GAPDH protein expression was used as loading 
control. Results are expressed as mean ± S.E.M from at least three independent 
experiments each performed in duplicate (panel C). Data were analyzed by 
Student’s t test. *p<0.05 and **p<0.005 vs non-treated; °p<0.05 vs cells treated 









GJ plaques are typically observed in the heart at the intercalated 
disks of adjacent cardiomyocytes [Revel & Karnovsky, 1967; 
Severs, 1990] where they facilitate electrical current flow that 
coordinates cardiomyocyte contraction to sustain its pump 
function [Severs et al., 2004]. In particular, Cx43 forms 
hemichannels, which are predominantly closed in healthy 
myocardium [Goodenough et al, 2004; Krysko et al., 2005]. 
However, they can open in response to electrical and chemical 
triggers, most notably during ischemia and inflammatory 
conditions [Saez et al., 2005; Saez & Leybaert, 2014; Wang et 
al., 2012a; Wang et al., 2013a; Wang et al., 2013b]. A prolonged 
opening of Cx43 hemichannels during ischemia may lead to loss 
of ionic gradients, excessive Ca
2+
 entry, cell swelling and 
cellular damage. Apart from being present at the sarcolemma, 
Cx43 has been identified in mitochondria of cardiomyocytes, 
where it plays a pivotal role in mediating the cardioprotective 
effect of ischemic preconditioning [Boengler et al., 2005]. 
Rodriguez-Sinovas and co-workers [2006] demonstrated that 
ischemic preconditioning induces Cx43 translocation from 
cytosol to mitochondria with a mechanism that involves Hsp90 
and TOM20. MCx43 is important in maintaining cellular 
mitochondrial homeostasis via regulating energy balance and 
calcium homeostasis [Wu et al., 2009], eliminating ROS [Jezek 
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et al., 2014], and regulating cellular apoptosis [Dando et al., 
2013], thereby providing cellular protective effects. 
Here, we evaluated the influence of mCx43 in  in vitro hypoxia 
model. Hypoxia was induced by means of Cobalt Chloride 
(CoCl2), a well-known hypoxia mimetic agent [Shi-Yun et al., 
2017], that is able to mimic the hypoxic response in many 
cellular process such as oxidative stress, dissipation of 
mitochondrial membrane potential, dysregulation of calcium 
homeostasis and consequent triggering of apoptosis [Wang et 
al., 2013]. In our experimental model, CoCl2 is able to induce 
hypoxia, like demonstrated by HIF-1α increased expression, 
without affecting cell viability in a drastic manner. In fact, we 
chose to use CoCl2 doses and incubation times that could induce 
hypoxia but did not give an excessive mortality because our goal 
was to observe early responses to induced damage. 
As demonstrated by Western blot analysis, and then confirmed 
by Immunofluorescence, in our experimental conditions CoCl2 
induces an increase of mCx43 expression to mitochondria with a 
mechanism that involves the well designed Hsp90/TOM20 
machinery system. In fact, blocking Cx43 interaction with 
Hsp90, through Radicicol, significantly reduced the 
mitochondrial import of Cx43. It is well known that the CoCl2-
induced hypoxia is characterized by dysregulation of calcium 
homeostasis, increase of reactive oxygen species, cell necrosis 
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and induction of pro-apoptotic signaling pathways [Wang et al., 
2013]. MCx43 impacts on respiratory function [Boengler et al., 
2012] and modulates the calcium overload, mitochondrial 
permeability transition and cell death [Srisakuldee et al., 2014]. 
Our data demonstrate that CoCl2 induces an increase in 
intracellular Ca
2+
 levels in H9c2 cells, as revealed by means of  
FURA 2-AM, instead inhibition of Cx43 translocation to 
mitochondria significantly rises the intracellular levels of [Ca
2+
], 
resulting in an increase of mitochondrial Ca
2+
 accumulation 
induced by CoCl2. The role of mCx43 in calcium homeostasis in 
hypoxic conditions is controversial. Gadicherla and co-workers 
indicate that mCx43 directly contribute to mitochondrial 
calcium entry/overload thus triggering cell injury/death 
pathways [2017]. On the other hand, other authors indicate that 
mCx43 exerts its cardioprotective effects by mitigating calcium 
overload, mitochondrial permeability transition and cell death 
[Srisakuldee et al., 2014]. This cardioprotective effect seems to 
be related to the increased mitochondrial calcium uptake and 
storage capacity during ischemia that helps to delay a rise in 
cytosolic calcium levels [Garcia-Dorado et al., 2012]. Our data 
support this hypothesis. Indeed, Jung and co-workers [2001] 
demonstrated that calcium levels are closely associated in 
mitochondrial ROS production and this suggests that chronic 
hypoxia-induced cell damages are related to mitochondrial 
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dysfunction. Here, we observed that CoCl2 induces an increase 
in mitochondrial oxygen radical species, as demonstrated by 
means of MitoSOX. The inhibition of Cx43 translocation to 
mitochondria by Radicicol, significantly increases the effect of 
CoCl2. It is well known that both mitochondrial calcium 
overload and ROS production induce mitochondrial membrane 
depolarization [Gadicherla et., 2017]. In fact, data obtained by 
means of TMRE showed that in our experimental conditions 
CoCl2-induced mitochondrial membrane depolarization was 
more evident and faster in presence of the pharmacological 
inhibitor of Cx43 translocation on mitochondria. Hypoxia of 
cardiomyocytes cause cardiac dysfunction due to its triggering 
cell injury and apoptosis. In fact, as demonstrated by our data, 
CoCl2 administration induces cytochrome c release, causing a 
significant increase of apoptotic process, as shown by FACS 
analysis with the use of propidium iodide. Furthermore, CoCl2 
induces an increase of caspase 9 levels and a concomitant 
reduction of procaspase 3 levels. Use of Radicicol significantly 
increases CoCl2-induced apoptotic signaling.  
In conclusion, our data obtained suggest that mCx43 is essential 
for the cytoprotection stultify the apoptotic process induced by 
chemical hypoxia and suggest that the presence of mCx43 is of 





Involvement of Connexin 43 in Calcium 
Impairment induced by Doxorubicin in a short-




Anthracyclines, used alone or in combination with other 
chemotherapeutic agents, are a class of antitumour drugs widely 
used for the treatment of a variety of cancers, such as breast 
cancer, lymphoma and melanoma [Hrdinaet al., 2000]. 
Anthracycline agents are antibiotics isolated from soil microbe 
Streptomyces peucetius [Jain et al., 2017] and the commonly 
used include Doxorubicin (DOXO), Daunorubicin, and 
Epirubicin [Gewirtz et al., 1999]. DOXO is one of the most 
widely used and successful prescribed broad-spectrum 
chemotherapeutic [Smuder et al., 2013], but, unfortunately, its 
usage is limited by the cumulative, dose-dependent 
cardiomyopathy. In fact, one major side effect of this class of 
chemotherapeutic drugs is cardiotoxicity [Octavia et al., 2012], 
leading to dilated cardiomyopathy and heart failure [Wong et al., 
2013]. The mechanisms of DOXO-induced cardiotoxicity are 
complicated and it is associated with the production of ROS and 
oxidation of lipids, DNA and proteins [Nordgren et al., 2014], 
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mitochondrial dysfunction, myofibril degeneration [Kavazis et 
al., 2016; Ghigo et al., 2016] and altered calcium handling by 
sarcoplasmic reticulum [Zhang et al., 2012]. Generation of ROS 
has been reported as the main mechanism that explains the 
pathophysiology of DOXO-induced cardiomyopathy [Fouad et 
al., 2011]. Similarly, other mediators such as Angiotensin II 
have also been found to play a critical role in the development 
of DOXO-induced cardiomyopathy [Toko et al., 2002]. The 
mechanisms of DOXO has been found to involve the activation 
of DOXO molecule into a more reactive semiquinone by 
mitochondrial complex I, resulting in increased oxidative stress 
[Carvalho et al., 2014]. However, Ren and co-workers [2012] 
reported that DOXO induces activation of both extrinsic and 
intrinsic apoptotic signaling pathways. Cardiac toxicity of 
DOXO was recently reported on electrocardiogram with a 
significant increase in heart rate, elevation of the ST segment, 
prolongation of the QT interval and an increase in T wave 
amplitude [Ammar et al., 2013]. Indeed, its disturbances in 
cardiac rhythm [Ferrans et al., 1997], changes in blood pressure 
[Medrano et al., 2001], reduction of ejection fraction and 
contractile function [Chatterjee et al., 2010] and cardiac dilation 




Anthracycline cardiotoxicity is classified as acute and chronic. 
Acute cardiotoxicity occurs during or soon after initiation of 
therapy. This is usually transient and self-limiting with a 
myopericarditis like picture, non-specific repolarization changes 
on ECG, dysrhythmias, troponin elevation, and transient LV 
dysfunction [Dazzi et al., 2001]. Chronic cardiotoxicity is 
arbitrarily classified as type 1 or early onset (typically detected 
within one year of completion of chemotherapy) and type 2 or 
late-onset (usually detected after the first year with an unlimited 
time frame of up to decades after completion of chemotherapy) 
[Lipshultz et al., 1991; Lipshultz et al., 2005]. Majority of the 
patients develop chronic cardiotoxicity within the first year of 
completing therapy [Cardinale et al., 2015]. The total lifetime 
cumulative dose of anthracycline is the most important 
determinant of anthracycline cardiotoxicity [Von Hoff et al., 
1979]. DOXO-induced cardiotoxicity is mainly related to 
accumulation of the repetitive doses required by the treatments, 
in fact total DOXO concentration cannot exceed 500 mg/m
2
. 
Recent evidence indicates that the damage caused by 
anthracyclines on cardiomyocytes is an early event, already 
evident after a single administration [Menna et al., 2008]. But 
until now most of the studies published report only the effects of 
long-term DOXO-administration [Zhang et al., 2014; O’ 
Connell et al., 2017]. 
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DOXO-induced cardiomyopathy is characterized by abnormal 
calcium homeostasis. Recently it has been demonstrated that 
DOXO administration is able to induce calcium dysregulation 
and Cx43 re-arrangement in a rat cardiomyoblast cell line 
already evident after a short-term administration [Pecoraro et al., 
2015 b]. Cx43 is functionally associated with calcium and Cx43 
remodelling might be responsible for intracellular calcium 
overloading induced by DOXO, thus resulting in ischemic 
arrhythmia [Kristia’n et al., 1998]. On the basis of these data, we 
analyzed the effect of DOXO-administration on Cx43 
















2.2 Materials and Methods  
 
2.2.1 Materials 
DOXO was purchased from Baxter manufacturing S.p.a. 
(Officina di Sesto Fiorentino, Florence, Italy). Where not 
indicated otherwise, antibodies used were purchased from Santa 
Cruz Biotechnology (DBA, Milan, Italy), and all other products 
were purchased from Sigma (Milan, Italy).  
 
2.2.2 Animals 
Six week old female C57BL/6j (weighting 20–22 g) were 
purchased from Charles River (Lecco, Italy). All experimental 
procedures that involve animals have been conducted in 
agreement with the Italian and European Community Council 
for Animal Care (DL. no. 26/2014 protocol number of 
Ministerial approvation DGSAF 13788-A 02/07/2015) and in 
accordance with the guidelines of the Guide for the Care and 
Use of Laboratory Animals of the National Institutes of Health.  
 
2.2.3 Experimental Protocols 
C57BL/6j mice were randomly divided in three groups  
(n = 6 for each experimental group). The doses used were 2 and 
10 mg/kg [Xujie et al., 2012; Wided et al., 2014] and they 




First Group: received one DOXO administration (2 or 10 mg/kg 
i.p.) and were sacrificed 24 h after the treatment; 
Second Group: received two DOXO administrations (2 or 10 
mg/kg i.p.) once a day for two days and were sacrificed three 
days after the first administration; 
Third Group: received three DOXO administrations (2 or 10 
mg/kg i.p.) once a day for three days and were sacrificed seven 
days after the first administration. 
Mice that received saline were used as control group. Cardiac 
function was monitored echocardiographically at baseline and 
before sacrifice. At the end of each experimental time, heart 
samples were collected and prepared for molecular biological 
analyses. 
 
Figure 15: Timetable. C57BL/6j female mice were randomly divided into three 
groups The 1st group received a single administration of DOXO (2 mg/Kg and 10 
mg/Kg; i.p.) and was sacrificed after 24h; the 2nd group received two administrations 
of DOXO (2 mg/Kg and 10 mg/Kg; i.p.) once every other day and was sacrificed 3 
days after the first injection; the 3rd group received three administration of DOXO (2 
mg/Kg and 10 mg/Kg; i.p.) once every other day and was sacrificed 7 days after the 
first injection. Control group received saline solution. At the end of experimental 






Mice were lightly anesthetized with 1–1.5% of isoflurane in 
oxygen until the heart rate stabilized to 400–500 beats per 
minute. Echocardiography was performed using VEVO 
(VisualSonic, Toronto, (Canada) instrument. Ejection fraction 
(EF), Fractional shortening (FS), Left Ventricular End-
Diastolic-Diameter (LVEDD), and Left Ventricular End-
Systolic Diameter (LVESD) were calculated using the VEVO 
analysis software (Toronto, Canada).  
 
2.2.5 Histological staining 
For histological analyses, hearts were embedded in OCT 
medium (Bio-Optica, Milan, Italy). Sections (7 μm) were fixed 
with acetone and stained either hematoxylin and eosin (H&E 
staining) to evaluate the cardiac structure following the 
administration of DOXO. Coverslips were finally mounted in 
mounting medium and all the photomicrographs were taken at 
20× magnification under the FluorescenceMicroscope (Axio 
Vision software). 
 
2.2.6 Protein Extraction and Western Blot Analysis  
Total proteins were extracted by homogenization of hearts with 
a dounce potter in lysis buffer (TRIS-HCl 50 mM, NaCl 500 
mM, protease inhibitors, PMSF 0.25 μM, NaF 50 mM, Na3VO4 
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0.2 mM). Protein concentrations were determined with the Bio-
Rad protein assay (BIO-RAD, Milan, Italy). Equal amounts of 
protein (50 µg) were loaded into an acrylamide gel and 
separated by SDS-PAGE under denaturating conditions. Blots 
were incubated with primary antibody anti-Cx43 (Sigma, 
1:8000), anti-pCx43 phosphorylate on Ser368 (Santa Cruz, 
1:250), anti-sarco/endoplasmic reticulum Ca2
+
-ATPase 
(SERCAII; Santa Cruz, 1:250), anti-phospholamban (PLB; 
Santa Cruz, 1:200), or anti-glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH; Santa Cruz, 1:1000, used as loading 
control) overnight at 4 °C. After incubation period with the 
primary antibodies, blots were washed in PBS 0.1% Tween. The 
appropriate secondary antibody anti-rabbit, anti-mouse, or anti-
goat (each diluted 1:4000) was added and allowed in incubation 
for 1 h at room temperature. Immunoreactive protein bands were 
detected by chemiluminescence using enhanced 
chemiluminescence reagents (ECL) in LAS 4000 (GE 
Healthcare, Björkgatan, Sweden). 
 
2.2.7 Mitochondrial Protein Extraction and Western Blot 
Analysis for Mitochondrial Cx43 and pCx43  
Mitochondrial proteins were extracted from homogenized hearts 
with a dounce potter in lysis buffer (sucrose 250 mM, K
+
 Hepes 
pH 7.5 20 mM, KCl 10 mM, MgCl2 1.5 mM, EDTA 0.1 mM, 
EGTA 1 mM, protease inhibitors, NaF 50 mM, Na3VO4 0.2 
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mM, PMSF 100 μM, DTT 1 mM, digitonin 0.025%) as 
previously reported [Pecoraro et al., 2015 b; Sardão et al., 2009]. 
The protein yield was quantified with the Bio-Rad protein assay 
(BIO-RAD, Milan, Italy). Western blot analysis for Cx43 or 
pCx43 was performed as described above. Primary antibody 
anti-TOM20 (Santa Cruz) was used as loading control. In order 
to verify the purity of mitochondrial protein extraction, a 
Western blot analysis was performed to evaluate the presence of 
proteins expressed only in the mitochondria (ox-Phos Complex 
II, Abcam, 1:7000) and the absence of proteins expressed in 




 ATPase, Abcam, 1:3000) 
[Boengler et al., 2005]. 
 






 concentrations were measured in primary 
cardiomyocytes, isolated from hearts of DOXO-treated mice and 
control mice. Hearts were washed with HBSS 0.1 mM Ca
2+
 (140 
mM NaCl, 5.4 mM KCl, 0.44 mM KH2PO4, 0.42 mM Na2H 
PO4, 4.17 mM NaHCO3, 26 mM CaNa-EDTA, 0.10 mM 
CaCl2·H2O, 5.0 mM HEPES and 5.5 mM dextrose). Next, hearts 
were cut in 1–2 mm sections and incubated at 37 °C in HBSS 
0.1 mM Ca
2+
 containing albumin 10 mg/mL, tryspin inhibitor 1 
mg/mL, taurine 5 mM, dithiothreitol 0.4 mg/mL, collagenase II 
0.6 mg/mL, and papain 0.6 mg/mL for 75 min. After the 
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incubation period, tissue fragments were removed by filtering 
the suspension with a 0.70 µ filter. Filtrate was centrifuged to 
collect the cardiomyocytes. Primary cardiomyocytes were 
loaded with the ratiometric fluorescent indicator dye FURA2-
AM (5 µM, 45 min, 37 °C) at a cell density of 3× 10
4
 cells/mL 
in HBSS 0.1 mM Ca
2+
. FURA2-AM excess was removed by 
washing the cells with HBSS and cardiomyocytes were then 
transferred to a spectrofluorimeter (Perkin-Elmer LS-50). As 
reported for FURA2-AM, the excitation wavelength was 
alternated between 340 and 380 nm, and the emission 
wavelength was 515 nm. The basal F340/F380 ratio was 
recorded and then treatment with ionomycin (1 µM), a calcium 
ionophore; thapsigargin (1 µM), an inhibitor of sarco(endo) 
plasmic reticulum; or carbonyl cyanide p-
trifluoromethoxypyhenylhydrazone (FCCP; 50 nM), a 
mitochondrial calcium depletory, was added into the cuvette in 
Ca
2+
-free HBSS and F340/F380 ratio was recorded 5 min after 
each stimulus induced. The ratio of fluorescence intensity of 
340/380 nm (F340/F380) is strictly related to intracellular free 
[Ca
2+
] [Popolo et al., 2011]. Results are expressed as delta 






 2.2.9 Immunohistochemical Analysis  
For immunohistochemical analyses, frozen cardiac tissues were 
embedded in OCT compound (Bio-Optica, Milan, Italy). 
Sections (7 µm) were incubated with mouse anti-Cx43 (1:250) 
and rabbit anti-TOM20 (1:250) for 2 h at room temperature. 
Then the slides were washed three times with PBS and 
incubated with secondary antibodies (FITC-conjugated anti 
mouse IgG and Texas red-conjugated anti rabbit IgG) for 1 h. 
DAPI was used to mark the nuclei. After mounting, coverslips 
were examined by using a Laser Confocal Microscope (Leica 
TCS SP5,Wetzlar, Germany).  
 
2.2.10 Statistical Analysis 
Data are reported as the mean ± standard error mean (S.E.M.) of 
at least three independent experiments. Statistical differences 
were assessed with Student’s t-test. p-values of less than 0.05 











2.3.1 Cardiac Functions 
Mice were subjected to echocardiography at baseline and before 
the sacrifice to analyze the main parameters of cardiac function. 
As reported in Table 1, DOXO administration affects Ejection 
Fraction (EF), Fractional Shortening (FS), Left Ventricular End-
Diastolic Diameter (LVEDD) and Left Ventricular End-Systolic 
Diameter (LVESD) in mice after a single injection of DOXO. 
Indeed, compared with control mice, DOXO-treated mice 
exhibited decreased cardiac systolic function as indicated by EF 
and FS, increased LVEDP and LVESD.  
 
Table 1: Effect of DOXO (2 or 10 mg/kg; i.p.) on Left Ventricular End-Diastolic 
Diameter (LVEDD), Left Ventricular End-Systolic Diameter (LVESD), Ejection 
Fraction (% EF), and Fractional Fhortening (% FS) after a single administration (1th 
group), two administrations (2nd group), or three administrations (3rd group). Results 
were expressed as mean ± S.E.M. from 6 mice/group 
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2.3.2 Histopathological examination 
To characterize the cardiotoxicity induced by DOXO, 
histopathological examination of heart tissue was performed as 
shown in Figure 16. Hearts from control mice showed regular 
cell distribution and normal myocardium architecture. Hearts 
sections of DOXO-treated mice fixed and examined 
microscopically exhibit vacuolar and granular degeneration, 
already evident in mice that received a single administration of 
DOXO. 
 
Figure 16: Immunostaining heart section of C57bl/6j mice which received a single 
administration (1st group), two administrations (2nd group) or three administrations 
(3rd group) of DOXO (2 mg/kg and 10 mg/kg; i.p.). Hematoxylin (red) and eosin 
(blue) staining of cardiac sections. All the photomicrographs were taken at 20× 






2.3.3 Doxorubicin Administration Alters Calcium Homeostasis 
It is well known that impairment in [Ca
2+
]i plays a pivotal role 
both in cardiotoxic activity of DOXO [Wallace et al., 2003] and 
in Cx43 activity [Bol et al., 2017]. In order to evaluate the 
effects of DOXO treatment on intracellular Ca
2+
 levels in our 
experimental model, primary cardiomyocytes from hearts of 
DOXO-treated mice and from control mice were isolated and 
loaded with the fluorescent dye FURA2-AM in Ca
2+
-free 
incubation medium (containing 0.5 mM EGTA). Our data 
indicate that DOXO treatment increased basal level of [Ca
2+
]i. 
Indeed the delta increase in [Ca
2+
]i induced by ionomycin, a 
Ca
2+
 ionophore, in cardiomyocytes from DOXO-treated mice 
was significantly (p<0.05) lower than that found in cells from 
control mice at all experimental time points (Figure 17A). An 
increase in basal Ca
2+
 levels may indicate that the cells are not 
capable of storing Ca
2+
 in intracellular stores. Accordingly 
(Figure 17B), delta increase in [Ca
2+
]i induced by thapsigargin, 
an endoplasmatic reticulum Ca
2+
 stores depletor, in 
cardiomyocytes from DOXO-treated mice was significantly 
lower (p<0.001) than that registered in cardiomyocytes from 
control mice, even in presence of a single DOXO 
administration, which may indicate a reduced Ca
2+
 storage in the 





]i induced by FCCP, a mitochondrial Ca
2+
 depletory, in 
cardiomyocytes from DOXO-treated mice was significantly 
(p<0.001) lower than that found in cells from control mice in all 
experimental groups (Figure 17C), suggestive of less build-up of 
Ca
2+
 also in the mitochondria. Among all regulatory 
mechanisms involved in intracellular Ca
2+
 homeostasis, 
SERCAII plays a pivotal role. Many studies report how changes 
in the expression and/or activity of SERCAII, regulated by 
phospholamban (PLB), are altered in many forms of 
cardiomyopathy [Periasamy et al., 2008]. Therefore, we 
analyzed the expression levels of SERCAII and PLB in the heart 
of DOXO-treated mice. Data obtained by Western blot analysis 
showed a significant (p<0.05) reduction of SERCAII expression 
always in mice that received a single DOXO administration 














Figure 17. Effect of DOXO on calcium homeostasis. Mice received a single 
administration (1
th
group), two administrations (2
nd 
group) or three 
administrations (3
rd
 group) of DOXO (2 or 10 mg/kg; i.p.) and primary 
cardiomyocytes were isolated by enzymatic digestion. Intracellular calcium 
content in cells suspension was evaluated by using ionomycin (1 μM) (A); 
reticulum calcium content was evaluated by means of thapsygargin (100 nM) 
(B) and mitochondrial calcium content was evaluated by using FCCP (50 
nM) (C). Results were expressed as mean ± S.E.M. of delta (δ) increase of 
FURA-2 AM ratio fluorescence (340/380 nm) from at least three independent 
experiments each performed in duplicate. Data were analyzed by Student’s t-
test. * p<0.05, ** p<0.005 and *** p<0.001 vs. control. Effect of DOXO on 
SERCA II (D) and PLB (E) expression. Mice received a single administration 
(1
th
group), two administrations (2
nd
 group), or three administrations (3
rd
 
group) of DOXO (2 mg/kg or 10 mg/kg; i.p.) and SERCA II and PLB 
expressions were detected by Western blot analysis into tissue homogenates 
from mice; GAPDH protein expression was used as loading control. Values 
were expressed as mean ± S.E.M. from at least three independent 
experiments each performed in duplicate. Data were analyzed by Student’s t-






2.3.4 Doxorubicin Administration Affects Cx43 Expression and 
Localization 
Besides alterations in Ca
2+
 homeostasis, several forms of 
cardiomyopathy, such as hypertrophy, and dilated and ischemic 
cardiomyopathy are also characterized by abnormal Cx43 
expression and distribution in the heart [Fontes et al., 2012]. As 
depicted in Figure 18A, DOXO-treatment induces a decrease of 
total Cx43 also evident in mice that received a single dose of 
DOXO. Western blot analysis performed on heart lysates of 
treated-mice confirmed that, compared to control mice, DOXO-
treated mice had a significant (p<0.05) reduction of Cx43 
expression, that could be observed in all experimental groups 
(Figure 18A). Phosphorylation of Cx43 affects its main 
biological properties [Jeyaraman et al., 2012]. In particular, 
phosphorylation on Ser368 is linked to metabolic and/or 
electrical uncoupling of gap junctions [Solan et al., 2009] and 
induces channels closure [Boengler et al., 2006]. Accordingly, 
Western blot analysis showed that DOXO-administration 
significantly (p<0.05) increases the expression of Cx43 
phosphorylated on Ser368 (Figure 18B). In addition to the 
function performed at GJ levels, it has recently been shown that 
Cx43 is also expressed at mitochondrial level, where it is 
involved in cardioprotection [Sakurai et al., 2013; Kalvelyte et 
al., 2003]. MCx43 levels increase in stress conditions such as 
ischemia-reperfusion [Rodriguez-Sinovas et al., 2006] or 
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DOXO-induced cardiotoxicity [Pecoraro et al., 2015 b]. Western 
blot analysis performed on mitochondrial lysates from hearts of 
DOXO-treated mice confirmed that Cx43 expression on 
mitochondria significantly (p<0.05) increases in DOXO-treated 
mice (Figure 18C). Mitochondrial expression of Cx43 
phosphorylated on Ser368 significantly (p<0.005) increased in a 
time dependent-manner in the heart of DOXO-treated mice 
(Figure 18D).  
Figure 18. Mice received a single administration (1
th
 group), two 
administrations (2
nd
 group), or three administrations 3
rd
 group) of DOXO (2 
mg/kg and 10 mg/kg; i.p.) and Cx43 and pCx43 expressions were detected by 
Western blot analysis into tissue homogenates from mice; GAPDH protein 
expression was used as loading control (A,B); Effects of DOXO on mCx43 
(C) and mCx43 phosphorylated on Ser368 (mpCx43) (D) expression were 
detected by Western blot analysis on mitochondrial protein lysate from mice; 
TOM20 protein expression was used as loading control. Values were 
expressed as mean ± S.E.M. from at least three independent experiments each 
performed in duplicate. Values are expressed as mean ± S.E.M. from at least 
three independent experiments each performed in duplicate. Data were 
analyzed by Student’s t-test. *p< 0.05, **p<0.005 and ***p< 0.001 versus 




ATPase and Ox-Phos 
Complex II were used as markers of sarcolemma (SF) and mitochondria 
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Immunofluorescence analysis performed on heart sections 
double-stained for Cx43 and TOM20, as a marker of 
mitochondria, confirmed an increased mitochondrial localization 












Figure 19 . Effect of DOXO (2 and 10 mg/kg; i.p.) on Cx43 localization in heart of 
C57BL/6j mice which received a single administration (1st group), two 
administrations (2nd group), or three administrations (3rd group). Frozen myocardial 
tissue sections were stained with Anti-Cx43 (green), TOM20 (red) and nucleus with 
DAPI (blue) and were determined by Immunofluorescence assay at confocal 






DOXO is one of the most widely used and successful antitumor 
drugs, but its cumulative and dose-dependent cardiotoxicity 
limits its clinical application [Zhang et al., 2009]. Mechanisms 
of DOXO-induced cardiotoxicity are very complex and remain 
elusive. They include a rearrangement of GJs, responsible for 
the cell-to-cell communication, leading to mitochondrial injury 
and promoting myocardial cell apoptosis [Singale et al., 2000; 
Nakamura et al., 2000], with an alteration of calcium 
homeostasis [Severs et al., 2008]. Many studies report the long-
term effects of DOXO while the effects of short-term treatment 
are not well elucidated. Doses of DOXO administered are 2 and 
10 mg/kg and are the lowest doses reported in literature [Xujie 
at al., 2012; Wided et al., 2014]. Recently, we have 
demonstrated that the damage caused by DOXO on cardiac 
functions is immediate after drug administration in a short-time 
model of DOXO induced-cardiomyopathy in vivo [Pecoraro et 
al., 2016]. Furthermore the echocardiography showed in 
DOXO-treated mice a decreased Ejection Fraction (EF) and 
Fractiona Shortening (FS) compared with control mice, and  an 
increased Left Ventricular End-Systolic Diameter (LVESD). 
These data suggest that the doses used in our experimental 
model are sufficient to induce clear signs of cardiac dysfunction. 
It is well known that contraction–relaxation cycle of the heart is 
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regulated by the sequential rise and fall of the cytosolic calcium 
concentration [Bers et al., 1997]. In our experimental model, we 
observed a significant dysfunction in Ca
2+
 homeostasis in 
DOXO-treated mice, as demonstrated by means of FURA 2-
AM. In line with earlier reports [Periasamy et al., 2008], 
Western blot analysis showed a significant decrease of 
SERCAII expression in the heart of DOXO-treated mice, 
confirming the central role of SERCAII in maintaining 
intracellular calcium homeostasis in the heart [Mattila et al., 
2016]. Moreover, our results showed a significant increased 
expression of PLB, a protein expressed in the sarcoplasmic 
reticulum membrane with inhibitory effects on SERCAII, in 
DOXO-treated mice, with a further alteration of cytosolic Ca
2+
 
content. Recent evidence points to a role of Cx43 on 





[Azarashvili et al., 2011]. In fact, abnormal expression of Cx43, 
the main GJ’s protein in the heart, has been reported in several 
forms of cardiomyopathies: i.e., hypertrophic, dilated, and 
ischemic cardiomyopathy [Pecoraro et al., 2015 a]. Our data 
demonstrate that DOXO admnistration significantly reduces 
Cx43 expression and, at the same time, increases the expression 
of its form phosphorylated on Ser368. In particolar, 
phosphorylation on Ser368 creates a “closed”, conformational 
state, blocking the cell-to-cell communication and the 
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propagation of harmful stimuli. Intracellular Ca
2+
 homeostasis is 
fine-tuned by the cyclical uptake and release by the different 
cellular compartments [Gadicherla et al., 2017]. Recent 
evidence points to a role of Cx43 in mitochondrial homeostasis 
of Ca
2+
 [Azarashvili et al., 2011; Boengler at al., 2013].  
The increase of mCx43 in cardiomyocytes can be induced by 
various stimuli, such as cellular stress and ischemic 
preconditioning, but its functional relevance is still unclear. It 
has been postulated that mCx43 is part of multiprotein complex 
that somehow controls mitochondrial homeostasis and that it 
forms hemichannels that serve as a conduit for ion flux [Miro-
Casas et al., 2009], like Ca
2+
. Interaction between proteins 
involved in this multiprotein complex is reinforced by PKC that 
mediates phosphorylation of the Cx43 at Ser368 residue [Waza 
et al., 2009]. In our experimental model, we found a significant 
increase of mCx43 and of mCx43 phosporylated on Ser368 
expression. MCx43 protects cardiomyocytes by mitigating Ca
2+
 
overload, mitochondrial permeability transition, and cell death 
[Gadicherla et al., 2017]. In agreement with this hypothesis, our 
data show that increased mCx43 and mCx43 phosphorylated on 
Ser368 expression is associated with a reduced accumulation of 
Ca
2+









Figure 20: Cardiotoxic Effects of Short-Term DOXO administration. A short-term 
administration of DOXO is able to induce significant changes in Ca2+ homeostasis and 
alterations in Cx43 expression and localization. Indeed, each DOXO administration can 










Cardioprotective effects of Diazoxide in 




Adenosine triphosphate-sensitive potassium channels (KATP) are 
abundantly expressed throughout the myocardium, however a 
definitive role in myocardial function has yet to be fully 
elucidated [Zhang et al., 2010]. KATP channels are formed as 
hetero-octamers of subunits that include 4 potassium inward 
rectifying (Kir) subunits and 4 regulatory subunits from the 
sulfonylurea receptor family (SUR1/2) (Nichols et al., 2013). 
Different combinations of Kir and SUR isoforms exist in 
different tissues, each with unique properties and function. The 
cardiac ventricular sarco KATP channel has been identified as 
comprising Kir6.2 and SUR2A as the predominant subunit 
combination [Kane et al., 2005]. KATP channels are ubiquitously 
expressed protein complexes hypothesized to provide a link 
between metabolic state and electrical excitability by virtue of 
their inhibition by ATP at normal physiological concentrations 
following direct binding of ATP to the Kir6 pore-forming 
subunit. In normal physiological conditions the channel is 
predominantly inhibite by ATP and are open during times of 
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stress, thus providing a “unique electrical transducer of  the 
metabolic state of the cell” [Nichols et al., 2013; Noma et al., 
1983]. Pharmacologic opening of KATP channels provides 
cardioprotection and mimics ischemic preconditioning in 
multiple animal models as well as in human myocytes [Henn et 
al., 2015]. Paradoxically, the cell surface (sarcolemmal) KATP  
channel has been implicated in myocyte swelling secondary to 
stress, and deletion of this channel provides resistance to 
myocyte swelling secondary to stress [Sellitto et al., 2011]. Cell 
surface KATP channels are composed of 4 pore–forming subunits 
(Kir6.2 or Kir6.1) and 4 of the ATP binding cassette family of 
membrane proteins (SUR1 or SUR2) [Flagg et al., 2010; Shyng 
et al., 1997].  
An early hypothesis used to define the role of KATP channels 
suggested that during an ischemic insult, activation of the 
sarcoKATP channel by a depletion of ATP and concurrent 
elevation in ADP, would cause a shortening of the cardiac action 
potential duration (APD) [Noma et al., 1983] and might lead to 
complete action potential failure, as the weakly rectifying KATP 
channel activity short-circuited the triggered depolarization. 
These actions could limit the rise in intracellular calcium and 
preserve cellular ATP. 
Diazoxide (DZX), a specific opener of mitochondrial KATP 
channels,  has been used in clinical practice since the early 
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1960’s to treat severe non-malignant and malignant 
hypertension in hospitalized adults and acute severe 
hypertension in hospitalized children. DZX is also used to treat 
hypoglycaemia. The mechanisms of DZX’s clinical action relate 
predominantly to the opening of pancreatic and smooth muscle 
KATP-channels [Coetzee et al., 2013]. Mitochondria are the 
major effectors of cardioprotection by mechanisms that open the 
mitochondrial KATP channel, including ischemic and 
pharmacological preconditioning [Garlid et al., 2013].  
 
Figure 21: A cartoon summary of the main potential effectors of diazoxide, depicting 
some of the potential mechanisms by which they may contribute to cardioprotection. 
[Janjua et al., 2014] 
 
The protective effect of DZX is equivalent to that of ischemic 
preconditioning, and DZX is often used as a pharmacological 
means to induce preconditioning [Coetze et al., 2013]. 
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Pharmacological preconditioning, mimicking ischemic 
preconditioning, is suggested as an intervention to reduce 
DOXO cardiotoxicity [Kelishomi et al., 2008].The drug has 
previously been described as an agent with a unique molecular 
target by opening of mitochondrial KATP-channels in 
cardioprotection . However, more recently a consensus seems to 
emerge that there are numerous effectors involved in the 
cardioprotective effects of DZX, and these effectors may 
synergistically contribute to its cardioprotective properties 
[Coetzee et al., 2013]. A possible effector involved in 
cardioprotection could be mCx43. So, we aimed to investigate if 
the pretreatment with DZX, could attenuate DOXO-induced 














3.2 Materials and Methods  
 
3.2.1 Materials 
DOXO was purchased from Baxter manufacturing S.p.a. 
(Officina di Sesto Fiorentino, Florence, Italy). Where not 
indicated otherwise, antibodies used were purchased from Santa 
Cruz Biotechnology (DBA, Milan, Italy), and all other products 




Six week old female C57BL/6j (weighting 20–22 g) were 
purchased from Charles River (Lecco, Italy). All experimental 
procedures that involve animals have been conducted in 
agreement with the Italian and European Community Council 
for Animal Care (DL. no. 26/2014 protocol number of 
Ministerial approvation DGSAF 13788-A 02/07/2015) and in 
accordance with the guidelines of the Guide for the Care and 







3.2.3 Experimental Protocols 
C57BL/6j mice were randomly divided in three groups  
(n = 12 for each experimental group). The doses used were 10 
mg/kg [Pecoraro et al., 2017 b] for DOXO and 20mg/kg for 
DZX [Jazayeri et al., 2013]. 
First Group (24h):  
 3 mice received a single DOXO administration (10 mg/kg i.p.) 
and were sacrificed 24 hours after the treatment. 
 3 mice received a single DZX administration (20 mg/kg i.p.) and 
were sacrificed 24 hours after the treatment. 
 3 mice were pretreated with DZX (20 mg/kg i.p.)  and then 
received a single DOXO (10 mg/kg i.p) administration and were 
sacrificed 24 hours after the treatment. 
 
Second Group(3 days): 
 3 mice received DOXO (10 mg/kg i.p.)  every other day and 
were sacrificed 3 days after the treatment. 
 3 mice received DZX (20 mg/kg i.p.) every other day and were 
sacrificed 3 days after the treatment. 
 3 mice were pretreated with DZX (20 mg/kg i.p.)  and then 
received DOXO (10 mg/kg i.p.) every other day  and were 





Third Group (7 days):  
 3 mice received DOXO (10 mg/kg i.p.)  every other day and 
were sacrificed 7 days after the treatment. 
 3 mice received DZX (20 mg/kg i.p.) every other day and were 
sacrificed 7 days after the treatment. 
 3 mice were pretreated with DZX (20 mg/kg i.p.)  and then 
received DOXO (10 mg/kg i.p.) every other day  and were 
sacrificed 7 days after the treatment. 
Mice that received saline were used as control group.  
Cardiac function was monitored echocardiographically at 
baseline and before sacrifice. At the end of each experimental 




Mice were lightly anesthetized with 1–1.5% of isoflurane in 
oxygen until the heart rate stabilized to 400–500 beats per 
minute. Echocardiography was performed using VEVO 
(VisualSonic, Toronto, (Canada) instrument. Ejection fraction 
(EF), Fractional shortening (FS), Left Ventricular End-
Diastolic-Diameter (LVEDD), and Left Ventricular End-
Systolic Diameter (LVESD) were calculated using the VEVO 




3.2.5 Protein Extraction and Western Blot Analysis  
Total proteins were extracted by homogenization of hearts with 
a dounce potter in lysis buffer (TRIS-HCl 50 mM, NaCl 500 
mM, protease inhibitors, PMSF 0.25 μM, NaF 50 mM, Na3VO4 
0.2 mM). Protein concentrations were determined with the Bio-
Rad protein assay (BIO-RAD, Milan, Italy). Equal amounts of 
protein (50 µg) were loaded into an acrylamide gel and 
separated by SDS-PAGE under denaturating conditions. Blots 
were incubated with primary antibody anti-Cx43 (Sigma, 
1:8000), anti-pCx43 phosphorylate on Ser368 (Santa Cruz, 
1:250), anti-sarco/endoplasmic reticulum Ca2
+
-ATPase 
(SERCAII; Santa Cruz, 1:250), anti-phospholamban (PLB; 
Santa Cruz, 1:250), or anti-glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH; Santa Cruz, 1:1000, used as loading 
control) overnight at 4 °C. After incubation period with the 
primary antibodies, blots were washed in PBS 0.1% Tween. The 
appropriate secondary antibody—anti-rabbit, anti-mouse, or 
anti-goat (each diluted 1:4000) was added and allowed in 
incubation for 1 h at room temperature. Immunoreactive protein 
bands were detected by chemiluminescence using enhanced 
chemiluminescence reagents (ECL) in LAS 4000 (GE 




3.2.6 Mitochondrial Protein Extraction and Western Blot 
Analysis for Mitochondrial Cx43 and pCx43  
Mitochondrial proteins were extracted from homogenized hearts 
with a dounce potter in lysis buffer (sucrose 250 mM, K
+
 Hepes 
pH 7.5 20 mM, KCl 10 mM, MgCl2 1.5 mM, EDTA 0.1 mM, 
EGTA 1 mM, protease inhibitors, NaF 50 mM, Na3VO4 0.2 
mM, PMSF 100 μM, DTT 1 mM, digitonin 0.025%) as reported 
in chaper  II. The protein yield was quantified with the Bio-Rad 
protein assay (BIO-RAD, Milan, Italy). Western blot analysis 
for Cx43 or pCx43 was performed as described above. Primary 
antibody anti-TOM20 (Santa Cruz) was used as loading control. 
In order to verify the purity of mitochondrial protein extraction, 
a Western blot analysis was performed to evaluate the presence 
of proteins expressed only in the mitochondria (ox-Phos 
Complex II, Abcam, 1:7000) and the absence of proteins 





Abcam, 1:3000) [Boengler et al., 2005]. 
 






 concentrations were measured in primary 
cardiomyocytes, isolated from hearts of mice treated as 
described above and from heart of control mice. Hearts were 
washed with HBSS 0.1 mM Ca
2+
 (140 mM NaCl, 5.4 mM KCl, 
78 
 
0.44 mM KH2PO4, 0.42 mM Na2H PO4, 4.17 mM NaHCO3, 26 
mM CaNa-EDTA, 0.10 mM CaCl2·H2O, 5.0 mM HEPES and 
5.5 mM dextrose). Next, hearts were cut in 1–2 mm sections and 
incubated at 37 °C in HBSS 0.1 mM Ca
2+
 containing albumin 10 
mg/mL, tryspin inhibitor 1 mg/mL, taurine 5 mM, dithiothreitol 
0.4 mg/mL, collagenase II 0.6 mg/mL, and papain 0.6 mg/mL 
for 75 min. After the incubation period, tissue fragments were 
removed by filtering the suspension with a 0.70 µ filter. Filtrate 
was centrifuged to collect the cardiomyocytes. Primary 
cardiomyocytes were loaded with the ratiometric fluorescent 
indicator dye FURA2-AM (5 µM, 45 min, 37 °C) at a cell 
density of 3 × 10
4
 cells/mL in HBSS 0.1 mM Ca
2+
. FURA2-AM 
excess was removed by washing the cells with HBSS and 
cardiomyocytes were then transferred to a spectrofluorimeter 
(Perkin-Elmer LS-50). As reported for FURA2-AM, the 
excitation wavelength was alternated between 340 and 380 nm, 
and the emission wavelength was 515 nm. The basal F340/F380 
ratio was recorded and then treatment with ionomycin (1 µM), a 
calcium ionophore; thapsigargin (1 µM), an inhibitor of 
sarco(endo) plasmic reticulum; or carbonyl cyanide p-
trifluoromethoxypyhenylhydrazone (FCCP; 50 nM), a 
mitochondrial calcium depletory, was added into the cuvette in 
Ca
2+
-free HBSS and F340/F380 ratio was recorded 5 min after 
each stimulus induced. The ratio of fluorescence intensity of 
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340/380 nm (F340/F380) is strictly related to intracellular free 
[Ca
2+
] [Popolo et al., 2011]. Results are expressed as delta 
increase of F340/F380, calculated as F340/F380 stimulus -  
F340/F380 basal. 
 
3.2.8 Immunohistochemical Analysis  
For immunohistochemical analyses, frozen cardiac tissues were 
embedded in OCT compound (Bio-Optica, Milan, Italy). 
Sections (7 µm) were incubated with mouse anti-Cx43 and 
rabbit anti-TOM20 for 2 h at room temperature. Then the slides 
were washed three times with PBS and incubated with 
secondary antibodies (FITC-conjugated anti mouse IgG and 
Texas red-conjugated anti rabbit IgG) for 1 h. DAPI was used to 
mark the nuclei.  
After mounting, coverslips were examined by using a Laser 
Confocal Microscope (Leica TCS SP5,Wetzlar, Germany).  
 
3.2.9 Statistical Analysis 
Data are reported as the mean ± standard error mean (S.E.M.) of 
at least three independent experiments. Statistical differences 
were assessed with Student’s t-test. p-values of less than 0.05 






3.3.1 Cardiac Functions 
Mice were subjected to echocardiography at baseline and before 
the sacrifice to analyze the main parameters of cardiac function. 
As reported in Table 2, DOXO administration affects Ejection 
fraction (EF), Fractional shortening (FS), Left Ventricular End-
Diastolic-Diameter (LVEDD), and Left Ventricular End-
Systolic Diameter (LVESD) in mice after a single injection of 
DOXO. Indeed, compared with control mice, DOXO-treated 
mice exhibited decreased cardiac systolic function as measured 
by Ejection fraction (EF) and Fractional shortening (FS), and 
consequently increased Left Ventricular End-Diastolic-Diameter 
(LVEDD) and Left Ventricular End-Systolic Diameter 















Table 2: Effect of DOXO (10 mg/kg; i.p.) or DZX (20 mg/kg; i.p.) or combined 
DZX+DOXO treatment on Ejection Fraction (% EF), Fraction Shortening (% FS), Left 
Ventricular End-Diastolic Diameter (LVEDD) and on Left Ventricular End-Systolic 
Diameter (LVESD), after a single administration (1th group), two administrations (2nd 
group), or three administrations (3rd group). Results were expressed as mean ± S.E.M. 
from 12 mice/group. 
 
 
3.3.2 Diazoxide Administration Alters Calcium Homeostasis 
 
In order to evaluate the effects of DOXO, DZX or combined 
DZX+DOXO treatment on intracellular Ca
2+
 levels in our 
experimental model, primary cardiomyocytes from hearts of 
treated mice and from control mice were isolated and loaded 
with the fluorescent dye FURA2-AM in Ca
2+
-free incubation 
medium (containing 0.5 mM EGTA).  
Our data demonstrated that DZX-pretreatment significantly 
affected Calcium homeostasis. In fact, as indicated in Figure 
22A and previously reported in Chapter II, DOXO 
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administration induced alterations in Ca
2+
 homeostasis by 
increasing intracellular free Ca
2+
 levels. Furthermore, as 
reported in Figure 22B and 22C, delta increase induced by both 
reticular ionophore (thapsigargin) and mitochondrial depletor 
(FCCP) in cardiomyocytes of DOXO-treated mice were 
significantly (p<0.05) lower than those of control mice, 
indicating higher basal levels of Ca
2+
. On the contrary, in 
primary cardiomyocytes of DZX+DOXO co-treated mice, 
reticular and mitochondrial  Ca
2+
 levels was comparable to those 
of control mice. 
SERCAII (Smooth Endoplasmic Reticulum Calcium ATP-Ase) 
protein is a Ca-dependent ATPasic pump that regulates the turn-
over of Ca
2+
 ions in the intracellular environment, between the 
sarcoplasmic reticulum and the cytosol, and its activation 
involves the reuptake of Ca
2+
 in the sarcoplasmic reticulum. The 
activity of SERCAII is, in turn, regulated by the PLB polymeric 
protein, which inhibits SERCAII depending on the degree of 
phosphorylation of the individual monomers of PLB [Periasamy 
et al., 2007]. The Western Blot analysis on heart homogenates 
shows, as reported in Figure 22D, that in the hearts of DOXO-
treated mice, SERCAII levels are reduced compared to the 
hearts of control animals. In contrast, DZX promotes the 
expression of SERCAII, in fact the expression of this protein 
increase significantly at all experimental times. The expression 
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of PLB in the heart of DOXO-treated mice is significantly 
(p<0.05) higher than control mice. In contrast, DZX pre-
treatment results in a progressive reduction of PLB expression 
(Figure 22E).  
Figure 22: Effect of DOXO (10 mg/kg; i.p.) or DZX (20 mg/kg; i.p.) or combined 
DZX+DOXO treatment on calcium homeostasis. Mice received a single 
administration (1th group), two administrations (2nd group), or three administrations 
(3rd group) of DOXO (10 mg/kg; i.p.) or DZX (20 mg/kg; i.p.) or combined 
DZX+DOXO treatment and primary cardiomyocytes were isolated by enzymatic 
digestion. Intracellular calcium content in cells suspension was evaluated by using 
ionomycin (1 μM) (A); reticulum calcium content was evaluated by means of 
thapsygargin (100 nM) (B) and mitochondrial calcium content was evaluated by using 
FCCP (50 nM) (C). Results were expressed as mean ± S.E.M. of delta (δ) increase of 
FURA-2 AM ratio fluorescence (340/380 nm) from at least three independent 
experiments each performed in duplicate. Data were analyzed by Student’s t-
test.*p<0.05, and **p<0.005 vs. control; #p<0.05 and #p<0.005 DZX+DOXO vs 
DOXO. Effect of DOXO or DZX or combined DZX+DOXO treatment on SERCA II 
(D) and PLB (E) expression. Mice received a single administration (1th group), two 
administrations (2nd group), or three administrations (3rd group) of DOXO (10 mg/kg; 
i.p.) or DZX (20 mg/kg; i.p.) or combined DZX+DOXO treatment and SERCA II and 
PLB expressions were detected by Western blot analysis into tissue homogenates 
from mice; GAPDH protein expression was used as loading control. Values were 
expressed as mean ± S.E.M. from at least three independent experiments each 
performed in duplicate. Data were analyzed by Student’s t-test. *p<0.05 and 




3.3.3 Diazoxide Administration Affects Cx43and pCx43 expression 
and localization 
As depicted in Figure 23A, DOXO-treatment induces a decrease 
of total Cx43 expression also evident in mice that received a 
single DOXO administration. Western blot analysis performed 
on heart lysates of DOXO-treated mice confirmed that, 
compared to control mice, Cx43 expression was significantly 
(p<0.05) reduced. On the contrary, Cx43 expression is higher in 
the heart of mice treated with DZX alone. DZX+DOXO co-
treatment increases the expression of Cx43 compared to DOXO-
treated mice. In fact, in the heart of DZX+DOXO co-treated 
mice the expression levels of Cx43 are comparable to those of 
control mice. 
Connexin phosphorylation plays an important role in regulating 
biological function [Hood et al., 2017 ]. Western blot analysis 
showed a significant (p<0.05) increase in Cx43 phosphorylated 
on Ser368 expression in DOXO-treated mice (Figure 23B) after 
7 days of treatment. DZX+DOXO co-treatment define a 
significant (p<0.001) reduction of pCx43 compared to DOXO-
treated mice. In fact, no significant differences are observed 







Figure 23: Effect of DOXO or DZX or combined DZX+DOXO treatment on Cx43 
(A) and pCx43 (B) expression. Mice received a single administration (1th group), two 
administrations (2nd group), or three administrations (3rd group) of DOXO (10 mg/kg; 
i.p.) or DZX (20 mg/kg; i.p.) or combined DZX+DOXO treatment and Cx43 and 
pCx43 expressions were detected by Western blot analysis into tissue homogenates 
from mice; GAPDH protein expression was used as loading control. Values were 
expressed as mean ± S.E.M. from at least three independent experiments each 
performed in duplicate. Data were analyzed by Student’s t-test. *p<0.05 vs. control; 
#p<0.05 DZX+DOXO vs DOXO 
 
3.3.4 Diazoxide Administration affects mitochondrial Cx43and 
pCx43 expression  
Western blot analysis performed on mitochondrial lysates from 
hearts of DOXO-treated mice show a significant (p<0.05) 
increase of mCx43 at all experimental times. In the hearts of 
DZX+DOXO co-treated mice we observed a time-dependent 
increase of mCx43 expression (Figure 24A). 
Regarding the expression levels of mCx43 phosphorylated on 
Ser 368 (Figure 24B) we observed an increase in the heart of 
DOXO-treated mice. It is to note that in the heart of 
DZX+DOXO co-treated mice mCx43 phosphorylated levels was 
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significantly higher than those of DOXO-treated mice, but a 
trend to reduction was observed throught the time. 
 
 
Figure 24: Effect of DOXO or DZX or combined DZX+DOXO treatment on 
mitochondrial Cx43 (A) and mCx43 phosphorylated (B) expression. Mice 
received a single administration (1th group), two administrations (2nd group), or three 
administrations (3rd group) of DOXO (10 mg/kg; i.p.) or DZX (20 mg/kg; i.p.) or 
combined DZX+DOXO treatment and mCx43 and mCx43 phosphorylated (mpCx43) 
expressions were detected by Western blot analysis into tissue homogenates from 
mice; TOM20 protein expression was used as loading control. Values were expressed 
as mean ± S.E.M. from at least three independent experiments each performed in 
duplicate. Data were analyzed by Student’s t-test. *p<0.05,**p<0.005 and 
***p<0.001 vs. control. Representative Western blots of Na+/K+ATPase and Ox-Phos 
Complex II were used as markers of sarcolemma (SF) and mitochondria (MF), 
respectively, to demonstrate the purity of the mitochondrial extracts (C). 
 
Immunofluorescence analysis performed on heart sections 
double-stained for Cx43 and TOM20, as a marker of 
mitochondria, confirmed an increased mitochondrial localization 







 Figure 25. Effect of  DOXO or DZX or combined DZX+DOXO treatment on 
Cx43 localization in heart of C57BL/6j mice which received a single 
administration (1st group), two administrations (2nd group), or three 
administrations (3rd group). Frozen myocardial tissue sections were stained with 
Anti-Cx43 (green), TOM20 (red) and nucleus with DAPI (blue) and were determined 






Chemotherapy with DOXO is limited by cardiotoxicity. Free 
radical generation and mitochondrial dysfunction are thought to 
contribute to DOXO-induced cardiac failure. In this study we 
wanted to investigate if opening of KATP-channels by Diazoxide 
(DZX) is protective against DOXO-cardiotoxicity, in a short-
term model of DOXO-induced cardiomyopathy in mice. 
In Chapter II we have shown that even a short-term model 
administration of DOXO is able to induce significant changes in 
calcium homeostasis and alterations in Cx43 expression and 
localization. Here, we focused on how the pretreatment with 
DZX attenuates DOXO-induced cardiac dysfunction in this 
model. 
The DZX tries to restore the major cardiac parameters altered by 
treatment with DOXO, Ejection fraction (EF), Fractional 
shortening (FS), Left Ventricular End-Diastolic-Diameter 
(LVEDD), and Left Ventricular End-Systolic Diameter 
(LVESD), as observed with echocardiograpghy in our 
experimental model. The heart rhythm is guaranteed by right 
regulation of Ca
2+ 
signalling. In Chapter II we observed a 
significant dysfunction in Ca
2+ 
homeostasis in DOXO-treated 
mice.  
Here, we demonstrated, by means of FURA-2AM, that the 
pretreatment with DZX keeps mitochondrial calcium levels 
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significantly higher than DOXO alone at all experimental times. 
Moreover, as demonstrated by Western blot analysis, the 
improvement of Ca
2+
 homeostasis, following pretreatment with 
DZX, was evidenced by the increase in SERCAII levels and a 
simultaneous progressive reduction in PLB expression.  
Since Gadicherla and collaborators [2017] underline the strong 
link between mitochondrial calcium homeostasis and Cx43, we 
wanted to see the fate of Cx43 following the pretreatment of 
DZX in our experimental model. 
As shown in the Chapter II, several forms of DOXO-induced 
cardiomiotoxicity are also characterized by redistribution of 
Cx43 expression in the heart. Moreover, its phosphorylation on 
Ser368, modulates the conductivity of the GJs [Lampe et al., 
2000], blocking the chemical coupling. This mechanism is 
consider a “defense” from the propagation of injurious stimuli. 
Here we show that the pretreatment with DZX restores the 
expression levels of Cx43 and of its phosphorylated form. 
Many studies report that DZX is able to induce translocation of 
PKC-ε from the cytosol to mitochondria in H9c2 cells, and, also, 
to induce its activation. The DZX-induced PKC-ε activation is 
implies in several cardioprotective properties [Coetzee et al., 
2013; Kim, et al., 2006]. In human cardiomyocytes, PKC-ε  is 
suspected to stabilize mitochondria, interacting with several 
targets [Barnett et al., 2008], such as Cx43 [Lia et al., 2013; 
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Lampe and Lau, 2000]. On the basis of our data, we 
hypothesized that in our experimental model, DZX pre-
treatment could form complexes with mCx43 and promote its 
phosphorylation at serine (Ser) 368 [Lia et al., 2013; Lampe and 
Lau, 2000], thus inducing the closure of hemichannels. In fact, 
data obtained by Western blot analysis showed an increase of 
mCx43 expression in all experimental conditions. Furthermore, 
we observed that DZX-pretreatment induces a significant 
increase of Cx43 phosphorylated expression on mitochondria 
compared to DOXO-treated mice. So we hypothesized that DZX 
promotes the closure of the hemichannels thus providing the 
storage of the Ca
2+
 in the mitochondria. In fact, as also discussed 
in the chapter I, the increased mitochondrial calcium uptake and 
storage capacity helps to delay a rise in cytosolic calcium levels 
which are more dangerous for cell viability. In fact, under high 
intracellular Ca
2+
 conditions, mitochondria may function as a 
buffer to control cytosolic Ca
2+ 
concentrations, thus delaying 
cell death. 
In conclusion, our data demonstrate that DZX represents a 
promising protective intervention to reduce the damage induced 
by DOXO. The cardioprotective effects of DZX are well 
documented. Here we reported that also Cx43 could be involved 
in these effects. In fact, the increase of Cx43 could be 




in DZX pre-treated mice, while the increased expression of 








Cx43 has multiple cellular locations and functions and changes 
in its expression and/or its channel and non-channel activities 
contribute to several cardiovascular pathologies (heart 
irreversible injury, arrhythmias). More research is needed to 
understand the pathophysiological alterations in Cx43 and to 
develop potential selective pharmacological approaches to 
reverse these effects. Therefore, in this doctoral project we 
investigated the involvement of Cx43, and in particular the 
crucial role of mCx43, in different cardiomyopaties models. 
In an in vitro model of chemical hypoxia induced by adding 
Cobalt Chloride on H9c2 cell, we demonstrated that mCx43 
plays a crucial role in cytoprotection by regulating calcium 
overload, mitochondrial ROS production, and mitochondrial 
membrane depolarization, consequently reduction of the 
triggering apoptotic pathway. 
Afterwards, in an in vivo DOXO-induced cardiotoxicity in a 
short-term mouse model we showed that the mCx43 protects 
cardiomyocytes by mitigating Ca
2+
 overload, balancing the 
alterations that trigger cardiac damage.  
In the end we observed that the pretreatment with DZX, an 
opener of mitochondrial KATP-channels, represents a promising 
protective intervention against DOXO-induced cardiotoxicity, 
reducing the calcium homeostasis alteration and trying to restore 
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the major cardiac parameters altered by DOXO treatment. This 
is in agreement with our hypothesis that mCx43 and DZX are 
involved in the cardioprotection mechanism. 
In conclusion, we identified the Cx43, in particular mCx43, as a 
new therapeutic target that might improve the treatment 
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